Thyrocare Technologies Limited has informed the Exchange regarding Change in Director(s) of the company.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare Technologies held its Board meeting on May 7, 2026, approving several key items. The Board recommended a final dividend of Rs. 7 per share for FY 2025-26, taking total dividend to Rs. 9.33 per share (post-bonus). The company appointed Price Waterhouse Chartered Accountants LLP as new statutory auditors for a 5-year term, replacing M S K A & Associates who completed their tenure. Two non-independent directors - Mr. Dharmil Nirupam Sheth and Dr. Dhaval Rajesh Shah - resigned citing personal commitments, with no material concerns reported. In their place, the Board appointed Mr. Uday Patel Kadam (COO & CBO at API Holdings) and Mr. Gaurav Verma (Chief Business Officer at API Holdings/PharmEasy) as Additional Directors. CEO Mr. Rahul Franklin Guha was re-appointed for another 5-year term from May 2027. The Board also approved investing up to Rs. 5.5 crore in Think Health Diagnostics Private Limited and amendments to the Memorandum of Association to expand business scope.
The resignation of two directors and simultaneous appointment of two API Holdings executives suggests a consolidation of parent company influence on the board. Shareholders may view the unchanged CEO, healthy dividend payout, and auditor change positively. The investment in subsidiary Think Health indicates continued focus on expanding the diagnostics platform.